2020 annual financial data
Avalo Therapeutics 2020 Operating margin
Direct answer
Operating margin was -402.34%.
Operating income was -26,953,000 USD and net income was -63,500,000 USD.
Operating cash flow was -40,539,000 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,699,000 USD
- Operating income
- -26,953,000 USD
- Net income
- -63,500,000 USD
- Operating cash flow
- -40,539,000 USD